Exscientia Plc (EXAI) Financials
Stock symbol EXAI is outdated, potentially delisted? Maybe it is available on other exchange?
EXAI Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2024 | 553.7 million | 179.3 million |
| March 31, 2024 | 598.4 million | 180.7 million |
| Dec. 31, 2023 | 650.7 million | 197.5 million |
| Sept. 30, 2023 | 671.0 million | 191.7 million |
EXAI Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2024 | -47.2 million | 2.9 million |
| March 31, 2024 | -43.4 million | -4.3 million |
| Dec. 31, 2023 | -2.6 million | 5.4 million |
| Sept. 30, 2023 | -46.6 million | 7.8 million |
EXAI Net Income
No data available :(
EXAI Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2024 | 370.3 million | 21.9 million | 26.7 million |
| March 31, 2024 | 225.4 million | 20.8 million | 24.2 million |
| Dec. 31, 2023 | 460.1 million | 21.1 million | 23.7 million |
| Sept. 30, 2023 | 447.2 million | 19.5 million | 21.9 million |
EXAI Shares Outstanding
EXAI Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2024 | 1.4 million | 31.8 million | 21.3 million | - |
| March 31, 2024 | 4.4 million | 29.8 million | 4.3 million | - |
| Dec. 31, 2023 | 4.2 million | 37.5 million | 14.8 million | - |
| Sept. 30, 2023 | 4.9 million | 38.7 million | 13.6 million | - |
EXAI Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2024 | 5.6 million | 9.8 million |
| March 31, 2024 | 6.7 million | 9.4 million |
| Dec. 31, 2023 | 3.1 million | 7.6 million |
| Sept. 30, 2023 | 10.8 million | 8.2 million |
EXAI Revenue by Segment
Graph available only for paid members. Upgrade to see it.
EXAI
Price: $4.84
52 week price:
Earnings Per Share: -1.52 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United Kingdom
Volume: 445040
Market Capitalization: 733.9 million